{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:36:11Z","timestamp":1791941771915,"version":"4.3.4"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1097\/aci.0b013e328364d843","type":"journal-article","created":{"date-parts":[[2013,8,14]],"date-time":"2013-08-14T17:49:54Z","timestamp":1376502594000},"page":"537-542","source":"Crossref","is-referenced-by-count":22,"title":["Pharmacoeconomics of anterior ocular inflammatory disease"],"prefix":"10.1097","volume":"13","author":[{"given":"Leonard","family":"Bielory","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basharut A.","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210128","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.anai.2012.01.006","article-title":"Allergic conjunctivitis and dry eye syndrome.","volume":"108","author":"Hom","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R2-14-20210128","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00130832-200410000-00014","article-title":"Ocular allergy and dry eye syndrome.","volume":"4","author":"Bielory","year":"2004","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R3-14-20210128","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ajo.2008.06.003","article-title":"Bacteriologic profile of the conjunctiva in the patients with dry eye.","volume":"146","author":"Hori","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R6-14-20210128","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/ICO.0b013e3181f7f363","article-title":"The economic burden of dry eye disease in the United States: a decision tree analysis.","volume":"30","author":"Yu","year":"2011","journal-title":"Cornea"},{"key":"R7-14-20210128","first-page":"S102","article-title":"Prevalence, burden, and pharmacoeconomics of dry eye disease.","volume":"14","author":"Pflugfelder","year":"2008","journal-title":"Am J Manag Care"},{"key":"R8-14-20210128","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2415-9-13","article-title":"Estimate of the direct and indirect annual cost of bacterial conjunctivitis in the United States.","volume":"9","author":"Smith","year":"2009","journal-title":"BMC Ophthalmol"},{"key":"R9-14-20210128","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1517\/14656566.3.5.541","article-title":"Update on ocular allergy treatment.","volume":"3","author":"Bielory","year":"2002","journal-title":"Expert Opin Pharmacother"},{"key":"R11-14-20210128","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.iac.2010.06.004","article-title":"Atopic dermatitis and keratoconjunctivitis.","volume":"30","author":"Bielory","year":"2010","journal-title":"Immunol Allergy Clin North Am"},{"key":"R12-14-20210128","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2500\/aap.2012.33.3525","article-title":"Allergic conjunctivitis: the evolution of therapeutic options.","volume":"33","author":"Bielory","year":"2012","journal-title":"Allergy Asthma Proc"},{"key":"R13-14-20210128","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1755-3768.2010.01993.x","article-title":"Comorbidities of dry eye disease: a nationwide population-based study.","volume":"90","author":"Wang","year":"2012","journal-title":"Acta Ophthalmol"},{"key":"R14-14-20210128","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2500\/aap.2007.28.3013","article-title":"Allergic rhinoconjunctivitis: burden of disease.","volume":"28","author":"Blaiss","year":"2007","journal-title":"Allergy Asthma Proc"},{"key":"R15-14-20210128","first-page":"213","article-title":"The ocular allergic response: a pharmacotherapeutic review.","volume":"39","author":"Slonim","year":"2004","journal-title":"Formulary"},{"key":"R16-14-20210128","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1067\/mai.2003.68","article-title":"Direct costs of allergic rhinitis in the United States: estimates from the 1996 Medical Expenditure Panel Survey.","volume":"111","author":"Law","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"R18-14-20210128","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2165\/00003495-200262110-00004","article-title":"Ocular allergy guidelines: a practical treatment algorithm.","volume":"62","author":"Bielory","year":"2002","journal-title":"Drugs"},{"key":"R19-14-20210128","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1076\/opep.11.1.17.26437","article-title":"Economic and quality-of-life impact of seasonal allergic conjunctivitis in Oxfordshire.","volume":"11","author":"Pitt","year":"2004","journal-title":"Ophthalmic Epidemiol"},{"key":"R20-14-20210128","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/09286580590967781","article-title":"The economic and quality of life impact of seasonal allergic conjunctivitis in a Spanish setting.","volume":"12","author":"Smith","year":"2005","journal-title":"Ophthalmic Epidemiol"},{"key":"R21-14-20210128","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2147\/OPTH.S30625","article-title":"Annual direct cost of dry eye in Japan.","volume":"6","author":"Mizuno","year":"2012","journal-title":"Clin Ophthalmol"},{"key":"R22-14-20210128","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/09286580600801044","article-title":"The annual cost of dry eye syndrome in France, Germany, Italy, Spain, Sweden and the United Kingdom among patients managed by ophthalmologists.","volume":"13","author":"Clegg","year":"2006","journal-title":"Ophthalmic Epidemiol"},{"key":"R23-14-20210128","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1517\/14728210903103818","article-title":"Emerging drugs for conjunctivitis.","volume":"14","author":"Origlieri","year":"2009","journal-title":"Expert Opin Emerg Drugs"}],"container-title":["Current Opinion in Allergy & Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACI.0b013e328364d843","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T16:51:58Z","timestamp":1636563118000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130832-201310000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/aci.0b013e328364d843","relation":{},"ISSN":["1528-4050"],"issn-type":[{"value":"1528-4050","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}